Polygenic Overlap Detected for Schizophrenia, CVD Risk
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Sept. 29, 2023 -- For individuals with schizophrenia, there is a genetic propensity for smoking and a reduced risk for obesity, according to a study published online Sept. 27 in the American Journal of Psychiatry.
Linn Rødevand, Ph.D., from the University of Oslo in Norway, and colleagues analyzed recent genome-wide association study results to assess overlapping genetic architecture between schizophrenia and cardiovascular disease (CVD) risk factors. To estimate the number of shared variants, the bivariate causal mixture model was applied, and the conjunctional false discovery rate approach was used to pinpoint specific shared loci.
The researchers identified extensive genetic overlap between schizophrenia and CVD risk factors, especially smoking initiation and body mass index (BMI; 8,600 and 8,100 variants, respectively). Specific shared loci were identified between schizophrenia and BMI, waist-to-hip ratio, smoking initiation, systolic blood pressure, diastolic blood pressure, type 2 diabetes, lipids, and coronary artery disease (304, 193, 293, 294, 259, 147, 471, and 35, respectively). Mainly concordant effect directions were seen for schizophrenia risk loci shared with smoking initiation, while opposite effect directions were mainly seen for the risk loci shared with BMI. Mixed-effect directions were seen for overlapping loci with lipids, blood pressure, waist-to-hip ratio, type 2 diabetes, and coronary artery disease. Mapped genes expressed in brain tissue and immune cells were implicated in functional analyses.
"We revealed polygenic overlap between schizophrenia and CVD risk factors, particularly BMI and smoking," the authors write. "The results indicate an inherent propensity to smoking in individuals with schizophrenia."
Two authors disclosed ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Informed Health App Aids Diabetes Outcomes
WEDNSDAY, May 15, 2024 -- Use of an artificial intelligence (AI)-informed health app aids diabetes outcomes and cuts atherosclerotic cardiovascular disease (ASCVD) risk, according...
Text Messages + Financial Incentives Boost Weight Loss at 12 Months
WEDNESDAY, May 15, 2024 -- Among men with obesity, an intervention with text messaging plus financial incentive significantly improves weight loss compared with a control group...
GLP-1 Receptor Agonist Use Increases Likelihood of Antidepressant Prescription
WEDNESDAY, May 15, 2024 -- Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.